SCHEMBL12850382

SCHEMBL12850382

C/C(=C/C(=O)O)C(=O)Nc1ccccc1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 6/20 0.58
▸ MAPT P10636 4/20 0.58
▸ KDM4E B2RXH2 2/20 0.58
▸ KMT2A Q03164 2/20 0.58
▸ TDP1 Q9NUW8 1/20 0.58
▸ ALDH1A1 P00352 1/20 0.58
▸ CYP1A2 P05177 1/20 0.58
▸ CYP2C19 P33261 1/20 0.58
▸ LMNA P02545 3/20 0.48
▸ HPGD P15428 2/20 0.48
▸ PARP1 P09874 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ NFKB1 P19838 1/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ NFKB2 Q00653 1/20 0.48
▸ RELA Q04206 1/20 0.48
▸ DHODH Q02127 1/20 0.48
▸ TRPM8 Q7Z2W7 1/20 0.48
▸ MMP1 P03956 2/20 0.47
▸ MMP2 P08253 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5177083 1.00 GAA (0.58) GAAMAPTKDM4EKMT2ATDP1
SCHEMBL15412073 1.00 GAA (0.58) GAAMAPTKDM4EKMT2ATDP1
SCHEMBL5177067 0.85 GAA (0.57) GAAMAPTKDM4EKMT2ATDP1
SCHEMBL5177074 0.85 GAA (0.57) GAAMAPTKDM4EKMT2ATDP1
SCHEMBL26659445 0.84 KDM4E (0.50) GAAMAPTKDM4EKMT2ATDP1
SCHEMBL26659382 0.84 KDM4E (0.50) GAAMAPTKDM4EKMT2ATDP1
SCHEMBL28100110 0.84 GAA (0.59) GAAMAPTKDM4EKMT2ATDP1
SCHEMBL5174596 0.83 RAB9A (0.65) GAAMAPTKDM4ETDP1ALDH1A1
SCHEMBL5691808 0.80 CA1 (0.52) KDM4EALDH1A1CYP1A2CYP2C19
SCHEMBL5177152 0.79 PARP1 (0.65) GAAMAPTKDM4EKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365730-A1 HIGH TEMPERATURE BENZOXAZINE RESINS, METHODS, AND USES THEREOF KANEKA CORPORATION (JP) 2023-11-16 — — US disclosed
EP-2686306-B1 BENZO[B][1,4]OXAZIN DERIVATIVES AS CALCIUM SENSING RECEPTOR MODULATORS LUPIN ATLANTIS HOLDINGS SA (CH) 2017-01-04 — — EP disclosed
US-9464063-B2 Benzo [B] [1,4] oxazin derivatives as calcium sensing receptor modulators LUPIN ATLANTIS HOLDINGS SA (CH) 2016-10-11 — — US disclosed
US-9464063-B2 Benzo [B] [1,4] oxazin derivatives as calcium sensing receptor modulators LUPIN ATLANTIS HOLDINGS SA (CH) 2016-10-11 — — US disclosed
US-20140018358-A1 BENZO [B] [1,4] OXAZIN DERIVATIVES AS CALCIUM SENSING RECEPTOR MODULATORS LUPIN LIMITED (IN) 2014-01-16 — — US disclosed
US-20140018358-A1 BENZO [B] [1,4] OXAZIN DERIVATIVES AS CALCIUM SENSING RECEPTOR MODULATORS LUPIN LIMITED (IN) 2014-01-16 — — US disclosed
WO-2012127388-A1 BENZO [B] [1, 4] OXAZIN DERIVATIVES AS CALCIUM SENSING RECEPTOR MODULATORS LUPIN LIMITED (IN) 2012-09-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365730-A1 HIGH TEMPERATURE BENZOXAZINE RESINS, METHODS, AND USES THEREOF KDM5C, DHX15, KDM5A GAA 1500/4885MAPT 969/4885KDM4E 135/4885
US-20140018358-A1 BENZO [B] [1,4] OXAZIN DERIVATIVES AS CALCIUM SENSING RECEPTOR MODULATORS CASR, RYR1, RYR2 GAA 1225/4885MAPT 2509/4885KDM4E 4297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback